Portal de Periódicos da CAPES

FAP imaging in rare cancer entities—first clinical experience in a broad spectrum of malignancies

2021; Springer Science+Business Media; Volume: 49; Issue: 2 Linguagem: Inglês

10.1007/s00259-021-05488-9

1619-7089

Katharina Dendl, Rebecca Finck, Frederik L. Giesel, Clemens Kratochwil, Thomas Lindner, Walter Mier, Jens Cardinale, Claudia Kesch, Manuel Röhrich, Hendrik Rathke, Heike Gampp, Jonas Ristau, Sebastian Adeberg, Dirk Jäger, Jürgen Debus, Uwe Haberkorn, Stefan A. Koerber,

Cardiac tumors and thrombi

Ga-FAPI (fibroblast activation protein inhibitor) is a rapidly evolving and highly promising radiotracer for PET/CT imaging, presenting excellent results in a variety of tumor entities, particularly in epithelial carcinomas. This retrospective analysis sought to evaluate the potential and impact of FAPI-PET/CT in rare cancer diseases with respect to improvement in staging and therapy, based on tracer uptake in normal organs and tumors.